William Blair Expands Biopharma Team with Terence Tan as MD

William Blair announced the appointment of Terence Tan as a Managing Director within its Healthcare investment banking team, with a focus on biopharma companies. Tan, based in New York, possesses over 19 years of biopharma investment banking experience, previously serving as a Managing Director at Cantor Fitzgerald and holding prior roles at Jefferies and UBS. William Blair, a leading global boutique, aims to deepen its advisory capabilities within the biopharma sector, ensuring strategic and customized financial solutions for its clients. Tan's background in providing investment banking guidance, including mergers and acquisitions, positions him as a valuable asset to the William Blair team. The firm prides itself on its comprehensive advisory services, backed by a global team, and has advised on over $810 billion in transaction volume between 2020-2024.